SummaryWe report on a qualitative investigation of the influence of emotions on the decision making of traders in four City of London investment banks, a setting where work has been predominantly theorized as dominated by rational analysis. We conclude that emotions and their regulation play a central role in traders' decision making. We find differences between high and low performing traders in how they engage with their intuitions, and that different strategies for emotion regulation have material consequences for trader behavior and performance. Traders deploying antecedent-focused emotional regulation strategies achieve a performance advantage over those employing primarily response-focused strategies. We argue that, in particular, response-focused approaches incur a performance penalty, in part because of the reduced opportunity to combine analysis with the use of affective cues in making intuitive judgments. We discuss the implications for our understanding of emotion and decision making, and for traders' practice.
In a cross-cultural study of the Asch effect, the present study found contemporary British and US university students did not differ significantly in their responses to unanimous peer-group opinion. While the number of obtained error responses was significantly less that those reported by Asch (1951, 1952, 1Y.56). it was also significantly greater than zero. It is suggested that, although the Asch effect has weakened over the past 30 years, it remains an observable minority behaviour: that is, there is still an identifiable small set of university students who will conform to group pressure in the Asch situation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.